-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
Allogene Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q1 2021 to Q4 2024.
- Allogene Therapeutics, Inc. Operating Margin for the quarter ending December 31, 2024 was -1.24M %, a 260% decline year-over-year.
- Allogene Therapeutics, Inc. annual Operating Margin for 2024 was -1.24M %, a 260% decline from 2023.
- Allogene Therapeutics, Inc. annual Operating Margin for 2023 was -345K %, a 60.4% decline from 2022.
- Allogene Therapeutics, Inc. annual Operating Margin for 2022 was -215K %, a 136083% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)